Plasmodium Falciparum Malaria (Drug Resistant) Recruiting Phase 4 Trials for Mefloquine (DB00358)

IndicationStatusPhase
DBCOND0114433 (Plasmodium Falciparum Malaria (Drug Resistant))Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03726593Drug Combinations of Atovaquone-Proguanil (AP) With ACTTreatment